| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 5e-05 | 1 |